AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15120716 — intervention group
Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) consumption
Number of subjects: 8
Study 15120716 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma-linolenic acid (2g/day)
Number of subjects: 8
Study 15120716 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of EPA with gamma-linolenic acid (GLA)
Number of subjects: 8
Study 15120716 — intervention group
Group type: EXPERIMENTAL
Intervention: Stearidonic acid (up to 1g/day)
Number of subjects: 8
Study 11789361 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium citrate
Number of subjects: 100
Study 11789361 — intervention group
Group type: COMPARATOR
Intervention: Fluid diet
Number of subjects: 100
Study 11789361 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 100
Study 9048688 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression model containing the Symptom Checklist Depression and Somatization scores, the one-month modified Roland-Morris score and the number of pain days in the past six months.
Number of subjects: 1213
Study 9048688 — intervention group
Group type: EXPERIMENTAL
Intervention: Recursive partitioning model
Number of subjects: 1213
Study 1645634 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency transcutaneous electrical nerve stimulation (TNS) at 2 Hz
Number of subjects: 46
Study 1645634 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 7235853 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly supportive group meetings
Number of subjects: 86
Study 31953144 — intervention group
Group type: EXPERIMENTAL
Intervention: Decoy present (higher priced vegetarian options)
Number of subjects: 0
Study 31953144 — intervention group
Group type: COMPARATOR
Intervention: Decoy absent (no higher priced vegetarian options)
Number of subjects: 0
Study 31292045 — intervention group
Group type: EXPERIMENTAL
Intervention: Super Skills for Life (SSL) program
Number of subjects: 123
Study 31292045 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control (WLC) group
Number of subjects: 123
Study 28643134 — intervention group
Group type: EXPERIMENTAL
Intervention: Volitional help sheet with implementation intentions
Number of subjects: 216
Study 28643134 — intervention group
Group type: COMPARATOR
Intervention: Volitional help sheet without implementation intentions (control)
Number of subjects: 216
Study 25194452 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy plus standard care
Number of subjects: 59
Study 25194452 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 59
Study 24473244 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythmic auditory-cued (RAC) training
Number of subjects: 20
Study 24473244 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed-dependent treadmill training (SDTT)
Number of subjects: 20
Study 24473244 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study 23155696 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic diet
Number of subjects: 58
Study 23155696 — intervention group
Group type: COMPARATOR
Intervention: Hypocaloric diet
Number of subjects: 58
Study 20100408 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% nifedipine and 1.5% lidocaine ointment
Number of subjects: 270
Study 20100408 — intervention group
Group type: COMPARATOR
Intervention: 1.5% lidocaine ointment alone
Number of subjects: 270
Study 18517168 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient positioning and timing during blood pressure measurement
Number of subjects: 0
Study 15817854 — intervention group
Group type: EXPERIMENTAL
Intervention: bIg (5 g)
Number of subjects: 52
Study 15817854 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 12421061 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid serial visual presentation of 2 written words at 53 ms/item with varying stimulus onset asynchrony (SOA) from 0 to 213 ms.
Number of subjects: 0
Study 10609394 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal adenosine infusion (108 to 3456 micrograms/min for 2 min)
Number of subjects: 8
Study 10609394 — intervention group
Group type: COMPARATOR
Intervention: Distal adenosine infusion (108 to 3456 micrograms/min for 2 min)
Number of subjects: 8
Study 8836079 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone-patellar tendon-bone autograft with Kennedy ligament augmentation device
Number of subjects: 100
Study 8836079 — intervention group
Group type: COMPARATOR
Intervention: Bone-patellar tendon-bone autograft without Kennedy ligament augmentation device
Number of subjects: 100
Study 1426214 — intervention group
Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate (A), 50-100 mg daily
Number of subjects: 85
Study 1426214 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 85
Study 3907864 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin A (Cy A)
Number of subjects: 69
Study 3907864 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatments
Number of subjects: 69
Study 31331234 — intervention group
Group type: EXPERIMENTAL
Intervention: Drift-adjusted A’Hern design
Number of subjects: 0
Study 31331234 — intervention group
Group type: EXPERIMENTAL
Intervention: Sargent and Goldberg design
Number of subjects: 0
Study 31331234 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated designs
Number of subjects: 0
Study 30672231 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial acupuncture stimulation (rTAS)
Number of subjects: 90
Study 30672231 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional western medication (Diazepam, 2.5 mg/day)
Number of subjects: 90
Study 30672231 — intervention group
Group type: COMPARATOR
Intervention: Placebo (starch capsule, once a day)
Number of subjects: 90
Study 30672231 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional western medication (Diazepam)
Number of subjects: 90
Study 30672231 — intervention group
Group type: COMPARATOR
Intervention: Placebo (starch capsule)
Number of subjects: 90
Study 27791225 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard ONS (200ml, 300kcal, 20g protein)
Number of subjects: 67
Study 27791225 — intervention group
Group type: COMPARATOR
Intervention: Energy-dense, small volume ONS (125ml, 300kcal, 18g protein)
Number of subjects: 67
Study 24842649 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion (150/300 mg/day) + Duloxetine (60 to 120 mg/day)
Number of subjects: 46
Study 24842649 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Duloxetine (60 to 120 mg/day)
Number of subjects: 46
Study 24842649 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion + Duloxetine
Number of subjects: 46
Study 22161845 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 2 mg
Number of subjects: 1514
Study 22161845 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 4 mg
Number of subjects: 1514
Study 22161845 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1514
Study 19727980 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (150 mg)
Number of subjects: 80
Study 19727980 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 80
Study 17324826 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% topical minoxidil
Number of subjects: 280
Study 17324826 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 280
Study 16240515 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindesse vaginal cream (single dose)
Number of subjects: 540
Study 16240515 — intervention group
Group type: COMPARATOR
Intervention: Cleocin vaginal cream (7 doses)
Number of subjects: 540
Study 12181117 — intervention group
Group type: EXPERIMENTAL
Intervention: N(G)‐monomethyl‐L‐arginine (L‐NMMA)
Number of subjects: 8
Study 12181117 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 8
Study 10981082 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxonidine
Number of subjects: 0
Study 10981082 — intervention group
Group type: COMPARATOR
Intervention: ACE inhibitors (enalapril, captopril)
Number of subjects: 0
Study 10981082 — intervention group
Group type: COMPARATOR
Intervention: Beta-blockers (atenolol)
Number of subjects: 0
Study 10981082 — intervention group
Group type: COMPARATOR
Intervention: Calcium-channel blockers (long-acting nifedipine)
Number of subjects: 0
Study 10981082 — intervention group
Group type: COMPARATOR
Intervention: Diuretics (hydrochlorothiazide)
Number of subjects: 0
Study 7817959 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraction of four first premolars
Number of subjects: 91
Study 7817959 — intervention group
Group type: COMPARATOR
Intervention: Nonextraction
Number of subjects: 91
Study 2351368 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyproheptadine (6 mg)
Number of subjects: 12
Study 2351368 — intervention group
Group type: EXPERIMENTAL
Intervention: DL Carnitine (1600 mg)
Number of subjects: 12
Study 2351368 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 7435899 — intervention group
Group type: EXPERIMENTAL
Intervention: Low spinal anaesthesia
Number of subjects: 183
Study 7435899 — intervention group
Group type: COMPARATOR
Intervention: Pudendal nerve block
Number of subjects: 183
Study 31159887 — intervention group
Group type: EXPERIMENTAL
Intervention: PermaNet 3.0 (n = 32)
Number of subjects: 5200
Study 31159887 — intervention group
Group type: EXPERIMENTAL
Intervention: Olyset Plus (n = 20)
Number of subjects: 5200
Study 31159887 — intervention group
Group type: COMPARATOR
Intervention: PermaNet 2.0 (n = 37)
Number of subjects: 5200
Study 31159887 — intervention group
Group type: COMPARATOR
Intervention: Olyset Net (n = 15)
Number of subjects: 5200
Study 28001301 — intervention group
Group type: EXPERIMENTAL
Intervention: TPF regimen (docetaxel, cisplatin, and 5‐fluorouracil)
Number of subjects: 231
Study 25873046 — intervention group
Group type: EXPERIMENTAL
Intervention: Ban-Lan-Gen granules
Number of subjects: 177
Study 25873046 — intervention group
Group type: COMPARATOR
Intervention: Oseltamivir
Number of subjects: 177
Study 25873046 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study 24090258 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical decolonization with intranasal mupirocin twice daily plus 4% chlorhexidine gluconate body wash daily for 5 days before surgery
Number of subjects: 693
Study 24090258 — intervention group
Group type: COMPARATOR
Intervention: Oral antibiotics (cephalexin) with statim pre- and postoperative doses
Number of subjects: 693
Study 22117991 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 μg/kg i.v. over 10 min followed by 0.2 - 0.7 μg/kg per h continuous i.v. infusion)
Number of subjects: 50
Study 22117991 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil (0.8 - 1.2 μg/kg i.v. over 1 min followed by 0.05 - 0.1 μg/kg i.v. per min)
Number of subjects: 50
Study 22117991 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 50
Study 22117991 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil
Number of subjects: 50
Study 19249426 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow-derived progenitor cells (BMC)
Number of subjects: 204
Study 19249426 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study 17084796 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinence goal selection during brief intervention
Number of subjects: 115
Study 17084796 — intervention group
Group type: EXPERIMENTAL
Intervention: Cutting down on drinking goal selection during brief intervention
Number of subjects: 115
Study 17084796 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who were abstinent at enrollment and chose to remain abstinent
Number of subjects: 115
Study 17084796 — intervention group
Group type: EXPERIMENTAL
Intervention: Recognition of situations putting them at risk for drinking and identifying alternatives to consumption
Number of subjects: 115
Study 15020545 — intervention group
Group type: EXPERIMENTAL
Intervention: In-school intervention (three lessons each lasting 50 min)
Number of subjects: 36
Study 15020545 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored out-of-school intervention (three tailored letters with smoking prevention messages)
Number of subjects: 36
Study 15020545 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined in-school and out-of-school intervention
Number of subjects: 36
Study 15020545 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study 11327055 — intervention group
Group type: EXPERIMENTAL
Intervention: ePTFE combined with weekly repeated local application of minocycline ointment for 8 weeks after membrane placement
Number of subjects: 40
Study 11327055 — intervention group
Group type: COMPARATOR
Intervention: ePTFE alone (control group)
Number of subjects: 40
Study 9623035 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular surveillance using a simple questionnaire administered by non-professional personnel (cases)
Number of subjects: 142
Study 9623035 — intervention group
Group type: COMPARATOR
Intervention: Control group (controls)
Number of subjects: 142
Study 7929726 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal pulsed colour Doppler ultrasound evaluation of the vessels surrounding the dominant follicle for blood flow impedance analysis
Number of subjects: 31
Study 7929726 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine test to explore the ability of the pituitary to release growth hormone
Number of subjects: 31
Study 7929726 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of anti‐granulosa cell auto‐antibodies in blood using an enzyme‐linked immunosorbent assay (ELISA)
Number of subjects: 31
Study 3791153 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrazine sulfate (60 mg, 3 times/d)
Number of subjects: 101
Study 3791153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 29771382 — intervention group
Group type: EXPERIMENTAL
Intervention: Siblings Coping Together intervention (SibCT)
Number of subjects: 30
Study 29771382 — intervention group
Group type: COMPARATOR
Intervention: Attention control (CG)
Number of subjects: 30
Study 27267228 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous TXA (1 g)
Number of subjects: 120
Study 27267228 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical TXA (1 g)
Number of subjects: 120
Study 27267228 — intervention group
Group type: COMPARATOR
Intervention: Control (no TXA)
Number of subjects: 120
Study 25719988 — intervention group
Group type: EXPERIMENTAL
Intervention: Y-MPL
Number of subjects: 53
Study 25719988 — intervention group
Group type: EXPERIMENTAL
Intervention: IR-MPL
Number of subjects: 53
Study 25719988 — intervention group
Group type: COMPARATOR
Intervention: Control (not applicable)
Number of subjects: 53
Study 22993101 — intervention group
Group type: EXPERIMENTAL
Intervention: lopinavir/ritonavir monotherapy (mLPV/r)
Number of subjects: 93
Study 22993101 — intervention group
Group type: COMPARATOR
Intervention: tenofovir/lamivudine/LPV/r (TDF/3TC/LPV/r)
Number of subjects: 93
Study 22993101 — intervention group
Group type: EXPERIMENTAL
Intervention: mLPV/r
Number of subjects: 93
Study 22993101 — intervention group
Group type: COMPARATOR
Intervention: TDF/3TC/LPV/r
Number of subjects: 93
Study 21207788 — intervention group
Group type: EXPERIMENTAL
Intervention: RelyX Unicem (RXU)
Number of subjects: 34
Study 21207788 — intervention group
Group type: COMPARATOR
Intervention: RelyX Unicem with selective enamel etching (RXU+E)
Number of subjects: 34
Study 18501329 — intervention group
Group type: EXPERIMENTAL
Intervention: Femtosecond laser surgery after RLE with multifocal IOL implantation
Number of subjects: 31
Study 15791928 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg melatonin
Number of subjects: 8
Study 15791928 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg melatonin
Number of subjects: 8
Study 12719501 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care intervention
Number of subjects: 354
Study 12719501 — intervention group
Group type: COMPARATOR
Intervention: Consult-liaison care
Number of subjects: 354
Study 10480714 — intervention group
Group type: EXPERIMENTAL
Intervention: CT examination for neurocysticercosis (NCC)
Number of subjects: 2723
Study 10480714 — intervention group
Group type: EXPERIMENTAL
Intervention: EITB assay for neurocysticercosis (NCC)
Number of subjects: 2723
Study 10480714 — intervention group
Group type: COMPARATOR
Intervention: CT examination in seizure-free random sample
Number of subjects: 2723
Study 10480714 — intervention group
Group type: COMPARATOR
Intervention: EITB assay in seizure-free random sample
Number of subjects: 2723
Study 10480714 — intervention group
Group type: COMPARATOR
Intervention: Comparison of epilepsy group vs random sample for CT diagnosis
Number of subjects: 2723
Study 10480714 — intervention group
Group type: COMPARATOR
Intervention: Comparison of epilepsy group vs random sample for EITB results
Number of subjects: 2723
Study 8524494 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid (500 mg intravenously after haemodialysis, 1-3 times a week)
Number of subjects: 4
Study 8524494 — intervention group
Group type: COMPARATOR
Intervention: Control group (7 patients with normal iron status and without resistance to erythropoietin)
Number of subjects: 4
Study 1683190 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine, 120 mg
Number of subjects: 60
Study 1683190 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine, 10 mg
Number of subjects: 60
Study 1683190 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study 649528 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral counselling
Number of subjects: 12
Study 649528 — intervention group
Group type: EXPERIMENTAL
Intervention: Client-centered counselling
Number of subjects: 12
Study 649528 — intervention group
Group type: COMPARATOR
Intervention: No counselling
Number of subjects: 12
Study 649528 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher approval
Number of subjects: 12
Study 31081008 — intervention group
Group type: EXPERIMENTAL
Intervention: Removable orthodontic device
Number of subjects: 25
Study 31081008 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed orthodontic device
Number of subjects: 25
Study 26718638 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamstring autograft
Number of subjects: 132
Study 26718638 — intervention group
Group type: COMPARATOR
Intervention: Tibialis allograft
Number of subjects: 132
Study 25327884 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium citrate (CIT) 900 mg kg(‐1)
Number of subjects: 11
Study 25327884 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 11
Study 23859625 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 66
Study 23859625 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 66
Study 21196836 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual toothbrushing with audiovisual instruction
Number of subjects: 16
Study 21196836 — intervention group
Group type: COMPARATOR
Intervention: Powered toothbrushing
Number of subjects: 16
Study 21196836 — intervention group
Group type: COMPARATOR
Intervention: Comparison of manual and powered toothbrushes
Number of subjects: 16
Study 19124807 — intervention group
Group type: EXPERIMENTAL
Intervention: ABVD
Number of subjects: 307
Study 19124807 — intervention group
Group type: EXPERIMENTAL
Intervention: BEACOPP
Number of subjects: 307
Study 19124807 — intervention group
Group type: EXPERIMENTAL
Intervention: CEC
Number of subjects: 307
Study 17314114 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 kcal/ml nocturnal enteral feed (NEF)
Number of subjects: 32
Study 17314114 — intervention group
Group type: COMPARATOR
Intervention: 1.5 kcal/ml nocturnal enteral feed (NEF)
Number of subjects: 32
Study 15526587 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant chemo-radiotherapy
Number of subjects: 80
Study 15526587 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 80
Study 11518451 — intervention group
Group type: EXPERIMENTAL
Intervention: Desogestrel 75 microg/day
Number of subjects: 84
Study 11518451 — intervention group
Group type: COMPARATOR
Intervention: Levonorgestrel 30 microg/day
Number of subjects: 84
Study 9489937 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/kg oral caffeine
Number of subjects: 93
Study 9489937 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg/kg oral caffeine
Number of subjects: 93
Study 9489937 — intervention group
Group type: COMPARATOR
Intervention: 0 mg/kg oral caffeine (control group)
Number of subjects: 93
Study 7827353 — intervention group
Group type: EXPERIMENTAL
Intervention: Adequate glycaemic control after 6 and 12 months
Number of subjects: 10
Study 7827353 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients before treatment
Number of subjects: 10
Study 7827353 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 10
Study 2901252 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroleptic treatment (medication continued)
Number of subjects: 100
Study 2901252 — intervention group
Group type: COMPARATOR
Intervention: Drug-withdrawn patients (some clinically relapsed)
Number of subjects: 100
Study 2901252 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with TD
Number of subjects: 100
Study 2901252 — intervention group
Group type: EXPERIMENTAL
Intervention: Nondyskinetic patients
Number of subjects: 100
Study 29904989 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week theory-based and culturally tailored dietary change program
Number of subjects: 70
Study 28794291 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol, 100 mg daily for 12 months
Number of subjects: 0
Study 28794291 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27004309 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTxA) injection (20 IU, 0.2 ml)
Number of subjects: 33
Study 27004309 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl solution injection (0.2 ml)
Number of subjects: 33
Study 23094638 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg + Amlodipine 10 mg
Number of subjects: 1111
Study 21193281 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiential‐existential therapy groups
Number of subjects: 11
Study 21193281 — intervention group
Group type: COMPARATOR
Intervention: Social support groups
Number of subjects: 11
Study 18420776 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing fitness magazine for 30 minutes
Number of subjects: 0